LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PI103 | 3.33 | uM | LJP6 | 72 | hr | 513 | 811 | 10401 | 0.0780 | 0.0301 |
MCF 10A | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 513 | 10721 | 10401 | 1.0308 | 1.0323 |
MCF 10A | QL-X-138 | 3.33 | uM | LJP6 | 72 | hr | 513 | 1712 | 10401 | 0.1646 | 0.1213 |
MCF 10A | QL-XII-47 | 3.33 | uM | LJP6 | 72 | hr | 513 | 818 | 10401 | 0.0787 | 0.0309 |
MCF 10A | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 513 | 638 | 10401 | 0.0614 | 0.0127 |
MCF 10A | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 513 | 616 | 10401 | 0.0593 | 0.0104 |
MCF 10A | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 513 | 8627 | 10401 | 0.8295 | 0.8206 |
MCF 10A | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 8789 | 10401 | 0.8450 | 0.8370 |
MCF 10A | XL147 | 3.33 | uM | LJP5 | 72 | hr | 513 | 9161 | 10401 | 0.8808 | 0.8746 |
MCF 10A | Saracatinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 2037 | 10401 | 0.1959 | 0.1542 |
MCF 10A | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 1150 | 10401 | 0.1106 | 0.0644 |
MCF 10A | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 513 | 10271 | 10401 | 0.9876 | 0.9869 |
MCF 10A | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 513 | 10151 | 10401 | 0.9760 | 0.9747 |
MCF 10A | SU11274 | 3.33 | uM | LJP5 | 72 | hr | 513 | 5510 | 10401 | 0.5298 | 0.5054 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 1665 | 10401 | 0.1601 | 0.1165 |
MCF 10A | TGX221 | 3.33 | uM | LJP5 | 72 | hr | 513 | 1456 | 10401 | 0.1401 | 0.0954 |
MCF 10A | Torin1 | 3.33 | uM | LJP6 | 72 | hr | 513 | 944 | 10401 | 0.0908 | 0.0436 |
MCF 10A | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 513 | 529 | 10401 | 0.0509 | 0.0016 |
MCF 10A | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 513 | 891 | 10401 | 0.0857 | 0.0382 |
MCF 10A | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 910 | 10401 | 0.0875 | 0.0401 |
MCF 10A | TWS119 | 3.33 | uM | LJP5 | 72 | hr | 513 | 6437 | 10401 | 0.6189 | 0.5992 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 513 | 4431 | 10401 | 0.4260 | 0.3962 |
MCF 10A | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 513 | 374 | 10401 | 0.0360 | -0.0140 |
MCF 10A | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 513 | 345 | 10401 | 0.0332 | -0.0170 |
MCF 10A | WYE-125132 | 3.33 | uM | LJP6 | 72 | hr | 513 | 896 | 10401 | 0.0862 | 0.0387 |